Clinical Trial Update: Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases

View source ↗

Summary

A completed clinical trial evaluating the effect of direct-acting antiviral drugs on gut microbiota in patients with hepatitis C–related chronic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Disease

Drugs mentioned

• Direct-acting antiviral drugs

Snippet

Sponsor: Assiut University | Conditions: Intestinal Microbiota Between Different Groups | Status: COMPLETED